New Malaria Antibody Drug Prevents Infection in Adults for 6 Months
TUESDAY, Nov. 1, 2022 (HealthDay News) — A new malaria antibody treatment may keep more people free of the sometimes deadly disease for up to six months in regions where infection rates are high. Instead of requiring the immune system to make enough antibodies, this experimental drug provides those whoContinue Reading










